Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that ...
Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered ...
Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of ...
Agilent Technologies (NYSE: A) had a Thursday to remember, at least as far as its equity was concerned. The medical device ...
Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.
Resolution Bioscience is a fast-growing, innovative leader in next-generation sequencing (NGS)-based oncology solutions. Combination brings together Resolution Bioscience’s noninvasive liquid biopsy ...
“In Q2, we delivered on our expectations and showed the resiliency of our diversified business. While we see the market improving, it is improving at a slower pace than anticipated,” said Padraig ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--For the sixth consecutive year, Agilent Technologies (NYSE: A) is ranked among the top 20 in Barron’s list of America’s 100 Most Sustainable Companies. The ...
Agilent Technologies' dividend strength, earnings growth, payout sustainability, and business outlook as the company ...
It has been about a month since the last earnings report for Agilent Technologies (A). Shares have added about 0.1% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Agilent topped Wall Street's consensus earnings estimate in its latest quarter. However, market uncertainties caused the company to provide weaker-than-expected guidance. Agilent reported fiscal Q2 ...